Brimonidina (tópica)
INCI: Brimonidine
Agonista alfa-2 adrenérgico tópico para la eritrosis de la rosácea. Contrae los vasos superficiales y elimina el enrojecimiento durante 9–12 horas.
Soothing
Evidence by route
Topical application
AProven efficacy. Two or more independent RCTs with instrumental endpoints.
The effect stays symptomatic and does not cure rosacea, only removes redness temporarily. A common issue is rebound erythema after withdrawal or overdose.
Tolerability and safety
Irritation potential
LowAllergen risk
LowPregnancy
CautionFrequently asked questions
¿Es seguro Brimonidina (tópica) durante el embarazo?
Brimonidina (tópica) se utiliza con precaución durante el embarazo. Conviene consultarlo con un dermatólogo o ginecólogo.